Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Engage Grants Program

Ryerson University

$25,000.00

Identification and the role of stress-activated molecular pathways in cell adaptation during**microbubble-coupled sonoporation

EF 2018-19

Résumé
MD Precision Inc. is a Canadian company that develops and manufactures ultrasound equipment for clinical*use, including medical imaging. MD Precision Inc. is looking to develop new devices and/or strategies that*couple ultrasound with microbubble-based sonoporation to kill solid tumours. In this process, microbubbles,*which are inert gas-filled lipid shells, are injected into the bloodstream and then subjected to a local ultrasound*field, which makes microbubbles in that field rapidly vibrate. These vibrations generate fluid ""micro-jets"" that*puncture the plasma membrane of nearby cells. Depending on the size and number of pores, cells either die,*internalize larger doses of drugs, or survive the assault. Overall, microbubble-coupled sonoporation imposes a*strong physical stress on cells. However, cells have evolved multiple molecular pathways that sense various*stresses like membrane damage. Ultimately, the goal of these stress-activated pathways is to alter gene*expression and/or protein function to adapt surviving cells to stress and improve survivability during*subsequent assaults. It is not known if and which stress-sensing pathways are engaged during the physical*stress imposed by microbubble-induced sonoporation and if surviving cells become stress-adapted. In this*project, my laboratory will use Western blotting, flow cytometry and ELISA assays to identify which*stress-activated pathways are engaged during microbubble-sonoporation in normal and transformed cell lines.*We will then use cell proliferation assays to examine if surviving cells become stress-adapted and better*survive subsequent assaults such as exposure to DNA-damaging agents. Finally, we will employ cell*proliferation assays to investigate if co-application of inhibitors of stress-activated pathways during*sonoporation neutralize stress adaption. This new fundamental knowledge of how cells respond and adapt to*physical stress imposed by microbubble-coupled sonoporation will help MD Precision Inc. to innovate*strategies that use microbubble-coupled sonoporation to more effectively destroy tumours. If successful, this*would position MD Precision Inc. to expand its market share, increase its labour force and benefit Canadians.
Programme
Engage Grants Program
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data

Tel que publié

Application id
529449-2018
Name nom
Botelho, Roberto
Department département
Chemistry and Biology
Organization id
43
Institution établissement
Ryerson University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
25000
Program id
EGP
Program name en
Engage Grants Program
Program name fr
Programme de subventions d'engagement partenariat
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1553
Committee name en
Ontario Internal Decision Committee
Committee name fr
Comité de décision interne pour l'Ontario
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5111
Research subject group en
Cell biology
Research subject group fr
Biologie cellulaire
Research subject en
Signal transduction
Research subject fr
Transduction de signal
Partie
1
Nb partie
1
Application title
Identification and the role of stress-activated molecular pathways in cell adaptation during**microbubble-coupled sonoporation
Keyword
NSERC
Application summary
MD Precision Inc. is a Canadian company that develops and manufactures ultrasound equipment for clinical*use, including medical imaging. MD Precision Inc. is looking to develop new devices and/or strategies that*couple ultrasound with microbubble-based sonoporation to kill solid tumours. In this process, microbubbles,*which are inert gas-filled lipid shells, are injected into the bloodstream and then subjected to a local ultrasound*field, which makes microbubbles in that field rapidly vibrate. These vibrations generate fluid ""micro-jets"" that*puncture the plasma membrane of nearby cells. Depending on the size and number of pores, cells either die,*internalize larger doses of drugs, or survive the assault. Overall, microbubble-coupled sonoporation imposes a*strong physical stress on cells. However, cells have evolved multiple molecular pathways that sense various*stresses like membrane damage. Ultimately, the goal of these stress-activated pathways is to alter gene*expression and/or protein function to adapt surviving cells to stress and improve survivability during*subsequent assaults. It is not known if and which stress-sensing pathways are engaged during the physical*stress imposed by microbubble-induced sonoporation and if surviving cells become stress-adapted. In this*project, my laboratory will use Western blotting, flow cytometry and ELISA assays to identify which*stress-activated pathways are engaged during microbubble-sonoporation in normal and transformed cell lines.*We will then use cell proliferation assays to examine if surviving cells become stress-adapted and better*survive subsequent assaults such as exposure to DNA-damaging agents. Finally, we will employ cell*proliferation assays to investigate if co-application of inhibitors of stress-activated pathways during*sonoporation neutralize stress adaption. This new fundamental knowledge of how cells respond and adapt to*physical stress imposed by microbubble-coupled sonoporation will help MD Precision Inc. to innovate*strategies that use microbubble-coupled sonoporation to more effectively destroy tumours. If successful, this*would position MD Precision Inc. to expand its market share, increase its labour force and benefit Canadians.